Search clinical trials for: bosutinib high flavour

Total 6632 results

Pfizer

Completed

Palatability (Taste) of Oral Formulations of Bosutinib

CML

Belgium
Pfizer

Completed

Evaluation of the Relative Bioavailability of Bosutinib Capsules Under Fed Condition and Estimation of Food Effect on Orally Administered Bosutinib Capsule

Healthy Participants

Belgium
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Study Comparing Two Different Tablet Formulations Of Bosutinib

Healthy

United States
Pfizer

Completed

Bioequivalence Study of Bosutinib Pediatric Capsule Relative to Commercial Tablet Under Fed Condition

Healthy Participants

Netherlands
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Study Comparing Two Different Tablet Formulations Of Bosutinib Under Fed Conditions

Healthy

United States
Pfizer

Completed

Absolute Bioavailability Of Bosutinib

Healthy

United Kingdom
Kyoto University
Pfizer; Kitasato University; Tokushima University; Tottori University

Recruiting

iPSC-based Drug Repurposing for ALS Medicine (iDReAM) Study

Amyotrophic Lateral Sclerosis

Japan
Pfizer

Completed

Study Evaluating SKI-606 (Bosutinib) In Advanced Malignant Solid Tumors

Neoplasms

United States
Children's Oncology Group
Pfizer; Erasmus Medical Center; Dutch Childhood Oncology Group; Innovative Therapies...

Active, not recruiting

Bosutinib in Pediatric Patients With Newly Diagnosed Chronic Phase or Resistant/Intolerant Ph + Chronic Myeloid Leukemia

Accelerated Phase Chronic Myelogenous Leukemia | Chronic Phase Chronic Myelogenous Leukemia | Blastic Phase Chronic Myelogenous Leukemia | Philadelphia Chromosome Positive CML

United States
Pfizer

Completed

Bosutinib In Subjects With Renal Impairment

Renal Insufficiency, Chronic | Renal Insufficiency, Acute | Renal Disease, End-Stage

United States
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Study to Determine the Effect of a High-Fat Meal on the Relative Bioavailability and Pharmacokinetics of a Single Dose of Bosutinib Administered Orally to Healthy Subjects

Healthy Subjects

United States
Pfizer

Recruiting

Safety And Efficacy Of Bosutinib (BLF)

Chronic Myelogenous Leukemia

Japan
Pfizer

Completed

Retrospective Observational Research Study to Describe the Real World Use of Bosutinib in a Single Centre in Scotland

Myeloid Leukemia

United Kingdom
Pfizer

Completed

Bioavailability of Bosutinib Administered as Capsule Contents Mixed With Applesauce or Yogurt Relative to Intact Capsules Under Fed Condition

Healthy Participants

Belgium
Pfizer

Completed

Bosutinib Treatment Extension Study Only For Subjects With Chronic Myeloid Leukemia (CML) Who Have Previously Participated In Bosutinib Studies B1871006 Or B1871008

Chronic Myeloid Leukemia

United States, Canada, Spain, China, Australia, Singapore, Korea, Republic of, France, Hong Kong, Netherlands, Turkey, Poland, Japan, United Kingdom, Argentina, Colombia, Hungary, Russian Federation, South Africa, Belgium, Brazil, Chil... and more
Pfizer

Completed

Study of Bosutinib in Japanese Adult Patients With Newly Diagnosed Chronic Phase Chronic Myelogenous Leukemia

Leukemia, Chronic Myelogenous

Japan
Cheerain HK Limited

Completed

Characterization of Product Use in Smokers Switching From Cigarettes to a RELX Electronic Nicotine Delivery System

Electronic Cigarette Use

United States
Pfizer
pH Associates

Completed

A Study To Describe The Real World Use Of Bosutinib In The UK And Netherlands

Chronic Myeloid Leukaemia

United Kingdom
Pfizer

Completed

Bosutinib For Autosomal Dominant Polycystic Kidney Disease

Polycystic Kidney, Autosomal Dominant

United States, Canada, Australia, Sweden, Spain, Poland, Korea, Republic of, Switzerland, United Kingdom, Moldova, Republic of, Italy, Czech Republic, Hungary, Lithuania, Romania, Slovakia, Turkey
Massachusetts General Hospital
Pfizer; Dana-Farber Cancer Institute; Brigham and Women's Hospital

Completed

Bosutinib in Adult Patients With Recurrent Glioblastoma

Glioblastoma

United States
Georgetown University
Alzheimer's Association

Completed

Impact of Bosutinib on Safety, Tolerability, Biomarkers and Clinical Outcomes in Dementia With Lewy Bodies

Dementia With Lewy Bodies

United States
PETHEMA Foundation

Completed

CML Treated With Bosutinib After Relapse (BOSTRO)

Chronic Myeloblastic Leukaemia

Spain
Pfizer

Completed

Study Evaluating SKI-606 (Bosutinib) In Subjects With Breast Cancer

Breast Neoplasms | Neoplasm Metastasis

United States, Ukraine, Russian Federation, Hong Kong, France, Australia, Poland, Malta
The Hospital for Sick Children

Terminated

Freezie Remedy to Alleviate Morning Sickness

Morning Sickness

Canada
Instituto de Investigación Hospital Universitario...
Creaciones Aromáticas Industriales S.A.

Completed

Encapsulated Flavour Effects on Satiety (SACIGOMA)

Overweight

Spain
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Study Evaluating The Pharmacokinetics (PK) And Safety Of Bosutinib In Subjects With Liver Disease And In Healthy Subjects

Breast Cancer | Leukemia, Myeloid, Chronic

Poland
Pfizer

Completed

Bioequivalence And Food Effect Study Of Bosutinib In Healthy Subjects

Philadelphia Chromosome Positive (Ph+) Chronic Myeloid Leukemia (CML)

Singapore
Gruppo Italiano Malattie EMatologiche dell'Adulto

Active, not recruiting

Bosutinib in Elderly Chronic Myeloid Leukemia (BEST)

Chronic Myeloid Leukemia

Italy
Fontem US LLC
Fontem Ventures BV

Completed

A Study to Evaluate Nicotine Uptake and Biomarkers in Adult Smokers Using mybluTM Electronic Cigarettes

Healthy Volunteers

United States
University of Bonn
Pfizer; RWTH Aachen University; Ludwig-Maximilians - University of Munich; Heidelberg... and other collaborators

Unknown

Phase II Study Testing the Tolerability and the Efficacy of Bosutinib in Chronic Phase CML Patients (BODO)

Chronic Myelogenous Leukaemia

Germany
Virginia Polytechnic Institute and State University
National Cancer Institute (NCI); University of Minnesota

Completed

Cigarette and E-cigarette Flavors Manipulations in the Experimental Tobacco Marketplace

Tobacco Use Disorder

United States
Pfizer
Developmental Therapeutics Consortium

Terminated

Safety And Efficacy Study Of Bosutinib In Patients With Philadelphia Chromosome Positive Chronic Myeloid Leukemia Previously Treated With One Or More Tyrosine Kinase Inhibitors

Previously Treated PH + CML

Spain, United States, Austria, Sweden, Germany, France, Italy, Norway
Aga Khan University
The Hospital for Sick Children; University of California; Bahauddin Zakariya...

Recruiting

Efficacy of Zinc Fortified Fermented Wheat Flour (EZAFFAW)

Inflammation | Diabetes | Malnutrition | Conjunctivitis

Pakistan
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Effect of Rifampin on Bosutinib When Both Are Given to Healthy People

Healthy
Yale University
National Institute on Drug Abuse (NIDA)

Recruiting

Effects of E-cigs vs Pouches on Cigarette Smoking and Addiction

Smoking | Nicotine Dependence | Smoking Behaviors

United States
University of Pennsylvania

Completed

The Effect of Sweet Flavoring on the Rewarding and Reinforcing Value of Cigarillo Use Among Young Adults (FLAV)

Tobacco Use | Cigar Smoking

United States
Neurological Associates of West Los Angeles
Pfizer

Enrolling by invitation

Study for the Use of TKIs for Treatment of Cognitive Decline Due to Degenerative Dementias

Dementia | Mild Cognitive Impairment

United States
M.D. Anderson Cancer Center
National Cancer Institute (NCI); Pfizer

Terminated

Bosutinib in Treating Patients With Chronic Myeloid Leukemia in Chronic Phase After Frontline TKI Failure

Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive | Blasts Under 15 Percent of Bone Marrow Nucleated Cells | Blasts Under 15 Percent of Peripheral Blood White Cells | Blasts Under 30 Percent of Bone Marrow Nucleated Cells | Blasts Under 30 Percent of Peripheral Blood White Cells

United States
Pfizer

Completed

Study Evaluating SKI-606 (Bosutinib) In Philadelphia Chromosome Positive Leukemias

Chronic Myeloid Leukemia

United States, Spain, Australia, Canada, Hong Kong, Singapore, United Kingdom, Germany, Netherlands, Chile, India, South Africa, Sweden, Peru, Argentina, Italy, Austria, Colombia, Brazil, China, Finland, Hungary, Korea, Republic of, M... and more
Pfizer

Completed

Study Evaluating SKI-606 (Bosutinib) In Japanese Subjects With Philadelphia Chromosome Positive Leukemias

Chronic Myelogenous Leukemia

Japan
Beijing Pearl Biotechnology Limited Liability Company

Completed

Study of a c-Met Inhibitor PLB1001 in Patients With PTPRZ1-MET Fusion Gene Positive Recurrent High-grade Gliomas

Glioma

China
Beijing Pearl Biotechnology Limited Liability Company

Completed

First-in-human Phase I Study of a Selective c-Met Inhibitor PLB1001

Non-Small Cell Lung Cancer

China
University of Milano Bicocca
IRCCS San Raffaele

Completed

Allogeneic Stem Cell Transplantation in Chronic Myeloid Leukemia Failing TKIs Therapy

Leukemia | BCR-ABL Positive | Myelogenous | Chronic

Italy
Monell Chemical Senses Center
HVMN (funding; holder of primary Department of Defense STTR contract)

Completed

Sensory Analysis and Taste Modulation of Ketone Esters

Flavor Perception in Normal, Healthy Adults

United States
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Study Evaluating Ascending Single-Dose Of Bosutinib Administered With Multiple Doses Of Ketoconazole To Healthy Subjects

Leukemia | Breast Cancer | Tumors

Netherlands
Yale University
National Institute on Drug Abuse (NIDA)

Not yet recruiting

Sex Differences in E-cig Perception: Study 1

Cigarette Smoking | Sex Differences | Nicotine Addiction | E-Cig Use
Neuromed IRCCS

Terminated

Supplementation With Polyphenol-Rich Foods and Atrial Fibrillation After a Cardiac Surgery (Polyphemus)

Coronary Heart Disease

Italy
Beijing Pearl Biotechnology Limited Liability Company

Recruiting

A Study of PLB1001 in Non-small Cell Lung Cancer With c-Met Dysregulation(KUNPENG) (KUNPENG)

Non-small Cell Lung Cancer

China
Hospital de Mataró
Nutricia Research

Recruiting

Effect of a Cooling Sensation Flavor on the Swallow Response in Post-stroke Patients With Oropharyngeal Dysphagia

Stroke | Oropharyngeal Dysphagia | Swallowing Disorder

Spain
St. Olavs Hospital
Odense University Hospital; Oslo University Hospital; University Hospital of... and other collaborators

Recruiting

Long-acting Low Dose Ropeginterferon for Chronic Myeloid Leukemia Treated With Bosutinib From Diagnosis (BosuPeg)

Chronic Myeloid Leukemia

Norway, Denmark, Finland, Sweden

Search clinical trials for: bosutinib high flavour

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Suriname

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations